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ABSTRACT 
Biofilm infections are currently of serious societal concern and implicated in different medical procedures such 
as surgery with implants and catheters, as well as being implicated in various respiratory diseases. Since a 
biofilm formation has proven to be less susceptible to traditional antibiotic treatment, finding a viable solution 
to this problem is being heavily researched. 
 
For this paper, research was performed by reviewing scientific literature concerning this topic area with a 
particular focus on the bacterial strains Streptococcus and Pseudomonas. In this paper these strains represent 
the Gram-negative and the Gram-positive bacteria. A literature review revealed that a viable solution to 
degrading biofilm would be the disruption of the cell-to-cell communication known as quorum sensing, which 
is a cell-density dependent mechanism and considered fundamental to bacteria’s ability to form biofilm. 
Literature utilizing in-vitro and in-vivo experiments were reviewed and it was found that disrupting quorum 
sensing via quorum quenching is showing promising results as a viable treatment method for mature biofilm. 
As a part of this paper, an experiment was performed that would serve to confirm already existing 
understanding of both the formation and degradation of biofilm formation with traditional antibiotics in-vitro. 
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Introduction  
 
Bacterial infection accounts for a significant proportion of medical treatment administered 
each year.  Infection is the result of a pathogenesis cascade, which involves bacteria entering 
the bodily system while being able to effectively evade the host’s immune system defense 
mechanisms long enough in order to multiply, colonize and subsequently thrive in population 
numbers that allow said pathogens to varying degrees, to effectively express virulence factors 
that are responsible for and instigate disease within the host [1]. Once pathogen population 
numbers have reached a critical limit, the pathogens communicate acquired population-density 
via a complex communication cascade termed ‘quorum sensing’ (QS). QS is a complex intra and 
interspecies chemical communication dialogue that allows bacteria to conclude upon self and 
other species, and calculate optimal behavior based upon ratio. QS allows bacteria to evade 
defense mechanisms by avoiding population detection until population numbers are acquired 
which are deemed sufficient to overpower the immune system upon rapid expression of 
virulence factors. Subsequently the host’s immune system defenses experience increased 
difficulty in combating the invading pathogens and their respective spontaneous and 
substantial expression of virulence factors. The host will typically become symptomatic 
according to the nature of the specific pathogen and infection context, which invariably 
necessitates treatment with exogenous substances, typically in the form of antibiotics or other 
antimicrobial treatments [2]. QS is considered to be fundamental to the pathogenesis of 
invading microbes and the controlling of their virulence factors, to the point that disrupting this 
communication mechanism is considered tantamount to removing the bacteria’s ability to 
successfully instill disease within the host [3].   
A significant proportion of infection-related medical treatment is attributed to post-surgery 
infection, including surgery that utilizes medical implants such as; central venous catheters, 
heart valves, ventricular assist devices, coronary stents, neurosurgical ventricular shunts, 
implantable neurological stimulators, arthro-prostheses, fracture-fixation devices, inflatable 
penile implants, breast implants, cochlear implants, intraocular lenses, dental implants and 
joint replacements [4]. Some experts consider that infection and re-infection post-surgery 
attributed to device-related infections constitutes upwards of 80% of infection prevalence for 
in-hospital infectious treatment. One of the larger determinants giving rise to the difficulty and 
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convoluted nature of fighting device-related infection is the pathogen’s proclivity to construct 
and subsequently take protective residence within a biofilm formation [1].   
 
Biofilm implications – Pseudomonas and Streptococci 
Biofilm formations are sessile pathogen communally derived matrices formed from polymeric 
substances produced by pathogens that can be adhered to implant and tissue surfaces [5]. A 
central tenant of the bacteria’s ability to effectively form and control biofilm formation is QS 
communication. Biofilm formation is not necessarily specific to medical implant substratum. 
The respiratory system is another typical site for biofilm formation to occur, especially in 
persons with compromised immune systems and respiratory illness such as cystic fibrosis. 
Pseudomonas is a species commonly related to respiratory infection and associated biofilm 
formation found in the lungs, while Streptococcus is a species of bacteria that is well known to 
form biofilm on medical implants such as those listed above [5][6].  Both bacteria species are 
well known to employ QS in order to time their virulent attacks to potentiate effect and form 
biofilm [7] [8]. 
Once pathogen derived biofilm constructs are formed, housed pathogens procure relative 
insulation from anti-microbial treatment, are easily able to derive nutrition from the biofilm 
matrix and better equipped to effectively orchestrate intercellular communication and express 
virulence factors, including virulent and anti-microbial-resistant horizontal gene expression 
[4].  It is approximated that biofilm affords housed pathogens upward of one thousand times 
greater protection from traditional antibiotic treatments relative to planktonic bacteria [9]. 
However it should be mentioned that certain antibiotic treatment protocols, involving pulsing 
of lower-dosages of anti-microbial medication, has shown some success against pathogens 
residing in biofilm [10]. 
 
Novel treatment method, QS disruption and proposed benefits 
It is well evidenced that treatment efficacy with traditional antibiotics is severely attenuated 
against biofilm-encapsulated pathogens.  Biofilm formation provides increased exposure to 
lower concentrations of antimicrobials and this substantially increases bacterial selection-
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pressure for antibiotic resistance, which gives light to the fact that more research is required in 
the area of alternative or non-traditional methods of treatment with regard to biofilm and 
associated pathogens [2]. A viable non-traditional antivirulent treatment method may be 
treatment that targets the disruption of the QS cascade. Antivirulent treatment does not seek 
to kill pathogens, but to neutralize their virulent factors, including QS which may have potential 
to severely retard the pathogen’s ability to effectively coordinate pathogenesis and 
construction of biofilm. It is proposed that in addition to neutralizing virulent factors, the 
nature of anti-virulent treatment does not promote selection of resistant bacteria, given that it 
focuses only on neutralizing virulent factors. This in itself is theorized to mitigate the potential 
for selecting resistant bacteria and creating drug-resistant strains while still effectively treating 
infection and disease [2]. Additionally, there is evidence to suggest that QS disruption treatment 
in the form of QS inhibitors can work as an effective synergist when coupled with conventional 
antimicrobial treatments such as antibiotics in animal models [1]. 
 
Problem formulation 
Initial interest in the topic area was established in anecdotal context through discussion with 
our group supervisor where the topic of biofilm and infection were brought forward, along with 
the associated implications toward efficacy of combating infection. Subsequent literature 
searches elucidated the fact that traditional antibiotics alone were not effective in combating 
progressed infection or the infrastructure of biofilm that can subsequently be formed and 
utilized by pathogens to become encapsulated for the effect of sustenance and protection. 
Additionally, relevant literature searches revealed that biofilm affords housed pathogens 
greater ability to acquire resistance and transcribe drug resistance genes via selection 
mechanisms. Drug resistant bacteria are an accelerating problem, with the emergence of strains 
usually being observed relatively quickly after initial introduction of new antibiotic treatments.  
Hospital acquired infections related to medical implants account for a significant amount of 
treatment causes and draw considerably upon resources. Treatment of hospital acquired 
infections related to implants is particularly laborious, as bacteria transmitted directly into the 
host’s tissue, skeletal bone or organ systems are afforded the opportunity to reside undetected 
until cell-density is acquired in order to initiate virulence expression. A significant proportion 
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of revision surgery related to medical implants is due to bacterial infection, which often 
includes biofilm formation and subsequent increased pathogenesis [11]. As biofilm forms in 
and around medical implants, invasive mechanical surgical intervention is typically required in 
order to combat hospital-acquired infections, with only tentative prognosis and associated 
complication risk. It is estimated that bacteria in biofilm formation are 1000 times less 
susceptible to traditional antibiotic treatment compared to their planktonic counterparts. In 
light of the attenuated efficacy of traditional treatments on biofilm, our group found it pertinent 
to perform a more specific literature search on possible alternative treatment methods and 
perform a review of the associated implications.  
 
Hypothesis and research question 
Literature searches revealed that alternatives to traditional treatments are currently being 
researched and progressed. One such group of treatments is termed ‘antivirulent’ treatments 
because they seek to neutralize the virulence factors expressed by pathogens as opposed to 
seeking to kill the pathogens – that is, being bacteriostatic as opposed to bactericidal. One of 
the greatest theorized benefits of this relatively novel approach is that by seeking only to 
disarm bacteria, the potential to select for resistant strains of bacteria is mitigated. This is one 
of the strongest arguments for furthering research in the area of antivirulent treatment.  
In addition to this, antivirulent treatment can aim at neutralizing the pathogen’s ability to 
communicate and express virulence factors as a potentiated collective. An aggregate form of 
colonized bacteria has more potential to overwhelm a host’s immune system’s ability to fight 
both pathogen and virulence factors. With this in mind and in the context of the issue of 
infection burden and attenuating efficacy of traditional treatments, it was hypothesized:  
 Since drug resistant bacteria and implied biofilm are becoming increasingly 
untreatable through traditional antibiotic and antimicrobial treatment, one way of treating these 
issues is through quorum sensing disruption and antivirulent treatment.  
In order to systematically examine our hypothesis in an exhaustive and thorough manner, the 
following research problem and sub-questions were formulated as a guide to the paper: 
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 Evaluating disruption of the quorum sensing cascade as an antivirulent treatment 
method for bacteria and biofilm. 
 
Sub questions 
 How effective are traditional antibiotic treatments in treating biofilm-encapsulated 
infections? 
 Is it possible to disrupt quorum sensing? 
 What novel methods are there for treating virulence through QS disruption? 
 
Aim of the study 
In order to evaluate disruption of quorum sensing as a viable alternative treatment method to 
traditional antibiotics, quorum sensing disruption will be systematically reviewed as a method 
of treatment for bacteria and biofilm formation contextually as dictated by the preceding 
question and sub-questions. Informational content on tenets central to QS disruption along 
with associated key mechanisms and implications to a holistic model will be explored in order 
to deduce a reductionist stance and provide a systemic determination of viability.  Current 
research will be examined, reviewed and discussed in a hope to further elucidate potential 
feasibility of this method, and direction for further key research will be posited.  
In addition to a thorough systematic literature review, a small lab-project will be undertaken 
and documented, that will serve as the student’s applied understanding of bacterial culture and 
culture-retardation/manipulated cell-density, controlling for specific antimicrobial treatments. 
This lab-work will be relatively superficial in the context of contributing knowledge to a 
viability vantage point, however it was deemed as an appropriate and enjoyable educational 
experience that would contribute to the student’s lab-work experience-capital and future 
study-subject choice. 
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Relation to semester theme 
Infection and biofilm formation is a major current health concern, in terms of prevalence and 
treatment efficacy. Hospital acquired infection drastically complicates otherwise relatively 
simple surgery and significantly increases mortality/morbidity-risk. In addition, infection and 
current treatment with traditional antibiotics is becoming increasingly difficult in light of 
burgeoning antibiotic resistant strains. As a result, cost to society both in terms of financial and 
life-quality is on the increase.  
A simpler, cheaper and more viable solution to this problem is therefore necessary and this 
specifically is the impetus for our project.  Using central tenets of natural science such as 
evidence-based review and experimental work according to controlled experimental design 
and acknowledged limitations of results, our semester project attempts to elucidate viable 
solutions to the increasingly insufficient traditional antibiotic treatment protocol.   
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Bacteria - an overview 
 
 
 
Bacteria are a kingdom of unicellular prokaryotic organisms with Archaean origins, ranging 
from 0.3 - 2.0 µm in size. They thrive in an extremely diverse range of environments, including 
those with varying temperatures, pH, humidity, pressure, gaseous environments, ecological 
niches and metabolic/nutritional realities.  
They may also be divided into Gram-positive and Gram-negative species. Gram-negative and 
Gram-positive bacteria have a similar internal structure, but the external structures differ in 
regard to their outer membranes. Gram-negative bacteria possess a cell wall composed of a thin 
layer of peptidoglycans and an outer membrane containing lipopolysaccharides, hence they are 
also referred to as diderms (figure 1). They are named Gram-positive or negative in relation to 
their ability to retain crystal violet stain. Gram-positive do retain it, whereas Gram-negative do 
 
Fig 1. Gram-positive and Gram-negative bacteria. Left: Gram-positive bacterial cells have a thick 
layer of peptidoglycan around the cell membrane, whereas Gram-negative (right) have a thinner layer 
of peptidoglycan and an outer membrane. The pili and flagella may or may not be present depending 
on the species of bacteria.  
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not - they possess a thicker peptidoglycan layer around their single cell membrane, and may be 
referred to as monoderms [12]. The difference in outer membrane structure and composition 
of these two broad classes of bacteria may also have significant medicinal implications with 
regard to treatment and administration [12]. In Gram-negative bacteria, the lipid constituent of 
the outer lipopolysaccharide layer acts as an endotoxin, and is predominantly responsible for 
toxic reaction causation within the host [14]. Broadly speaking, this is a large determinant 
towards the tendency for Gram-negative bacterial species to be more pathogenic than Gram-
positive species, since they possess an inherent resistance to traditional antibiotics owing to 
the structure and functional capacity of their outer membrane. 
Structurally, bacteria have evolved into a plethora of different shapes and sizes. Bacteria 
possess no nucleus, they possess DNA in the form of a nucleoid or plasmid, and they do not have 
any membrane bound cell organelles, and often have cell walls outside their cell membranes. 
They may also possess a variation of structures like flagella, pili and capsules, specific to species 
and their environments. Flagella in particular allow bacteria motility which effectively serves 
their ability to better relocate proximally for nutrition and also for a more conducive 
environment within which to survive.   
Bacteria are able to inhabit the environment of the human organism and cause harmful 
infections. The discovery of antibiotics in the beginning of the 20th century led to the 
proliferation of drugs for infection therapy and consequently the development of antibiotic 
resistance in bacteria.  
Bacteria develop antibiotic resistance through horizontal gene transfer with the use of pili and 
point mutations in their genome. They reproduce rapidly through binary fission, a form of 
asexual reproduction, with some species of bacteria doubling colony size in less than ten 
minutes [13]. Due to their ability to reproduce rapidly, bacteria develop resistance to 
antibiotics which has led to the rapid emergence of multidrug resistant bacteria. Drug resistant 
bacteria can cause aggressive and untreatable infections in patients. 
Bacteria can exist in a free-floating state known as a planktonic state. They may also form 
biofilms on a number of biotic or abiotic surfaces. After a bacterial cell achieves adhesion, using 
adhesion proteins, to a surface it begins to proliferate. As the number of bacteria in this adhered 
colony multiplies, they exude polysaccharides and other substances. Eventually a capsule of 
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sorts is formed around this growing colony, encasing the bacterial cells within it. It is within 
this biofilm matrix of exudates that bacteria lie and proliferate.  
Bacteria may produce virulence factors like exotoxins to obtain nutrition by breaking down 
host tissue, causing necrosis. Cell-adhesion to either biotic or abiotic surfaces is a tactic bacteria 
successfully employ, which along with the formation of a biofilm matrix allow bacteria to lie 
undetected until they reach a cell density necessary to cause aggressive infection and 
successfully fight their host’s immune system [15]. The system of communication bacteria use 
to produce these cell density dependent virulence factors is known as Quorum Sensing. We will 
explore QS in detail in the chapter Quorum sensing – an overview.  
Some traditional antibiotics target the cell walls of bacterial cells, and the bacteria that develop 
resistance to them may use efflux pumps within their cell walls to eject antibiotics faster than 
they can have any effect, whilst they share their improved ability to expel drugs through 
horizontal gene transfer. The efflux pump is an active transport protein, located in the 
cytoplasmic membrane of most cells. These pumps are responsible for pumping out toxic 
substances based on their physiochemical properties, and since antibiotics are amphilic, they 
are easily recognized and disposed of by the efflux pump. In our paper we will be exploring 
novel methods of antibacterial treatment, concentration on bacteriostatic rather than 
bactericidal methods.  
The general functions of traditional antibiotics are to either kill bacteria or to slow their growth 
by preventing them from reproducing; thus classifying them into the groups, bactericidal and 
bacteriostatic agents respectively [18]. Antibiotics work in a way so that they kill only a certain 
bacteria and none of the cells in the body [16].  
Antibiotics depend on various factors in order for them to be successful in their treatment; 
examples of these factors are the host defence mechanisms and the location of the infection as 
well as the bacterial growth phase, as constant metabolic activity and bacterial cell division is 
often essential [17].  
The majority of antibiotics target the bacterial functions or the growth procedures and are 
classified from their chemical structure, mechanism of action or the variety of activity. 
Antibiotics are further classified due to their specific targets. Antibiotics that target specific 
types of bacteria are known as “narrow-spectrum” antibiotics; examples of this are Gram-
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negative and Gram-positive bacteria. “Broad-spectrum” antibiotics are therefore effective on a 
broad range of bacteria [19]. 
Antibiotics that target the cell wall or the cell membrane or impede essential bacterial enzymes 
have bactericidal activities; and those that target protein synthesis are commonly 
bacteriostatic.  
In our experiment we have used the aminoglycoside antibiotic Tobramycin to treat the 
Pseudomonas planktonic and biofilm cultures. Aminoglycosides in general have potential 
antibiotic mechanisms such as interfering with the proofreading process which causes an 
increased rate of error in synthesis with premature termination [20]. Aminoglycoside 
antibiotics, such as Tobramycin, also act as protein synthesis inhibitors and are known to be 
especially effective against Pseudomonas strains. In order to inhibit protein synthesis 
Tobramycin irreversibly binds to only the one of two aminoglycoside binding sites on the 30-S 
ribosomal subunit which inhibits ribosomal translocation at the ribosomal A-site, which affects 
the processing of polypeptides. This further implicates production of proteins and by extension 
- gene expression. Tobramycin may also disrupt the bacterial membrane by binding to 16-S 16-
S rRNA. An active transport mechanism for aminoglycoside uptake is essential in the bacteria 
in order to achieve a sufficient intracellular concentration of Tobramycin [21]. Usually protein 
synthesis inhibition of aminoglycosides do not have a fast or any bactericidal effect which is 
often seen on susceptible Gram-negative bacteria [20]. 
 
Pseudomonas  
Pseudomonas are a species of bacteria that cause pathogenesis in humans. They are a Gram-
negative, rod shaped bacteria, possessing an intrinsic resistance to antibiotics and 
disinfectants, including outer membrane permeability and multi drug resistance pumps. They 
may produce a number of virulence factors in biofilm infections, causing symptoms in patients 
(table 1).   
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Streptococci   
Streptococci are Gram-positive, spherical facultative anaerobic bacteria. They are usually 
present in chains, and are strong fermenters of carbohydrates. They also develop antibiotic 
resistance through horizontal gene transfer. Streptococci are also known to cause biofilm 
infections on medical implants and in human dental plaques (table 2). 
 
 
ORGANISM VIRULENCE FACTORS CLINICAL MANIFESTATIONS 
PSEUDOMONAS 
AERUGINOSA 
1. polar flagellum (H 
antigen) 
2. hemolysin 
3. collagenase 
4. elastase 
5. fibrinolysin 
6. phospholipase 
7. DNAase 
8. some strains possess an 
antiphagocytic capsule 
1. exotoxin A (similar to diphtheria toxin): inhibits protein 
synthesis by blocking EF2 
      a. pneumonia (cystic fibrosis and immunosuppressed                      
pts) 
      b. osteomyelitis (diabetics, IV drug users, children) 
      c. burn wound infections 
      d. sepsis 
      e. UTI 
      f. endocarditis (IV drug users) 
      g. malignant external otitis 
      h. corneal infections in contact lens wearers  
Table 1. The various virulence factors coded for by Pseudomonas aeruginosa.  Also shown are 
the clinical manifestations of virulence factors.  
 
 
ORGANISM VIRULENCE FACTORS CLINICAL MANIFESTATIONS 
STREPTOCOCCUS   
STREPTOCOCCUS PNEUMONIAE 
(ORAL COLONIZATION) 
1. capsule (83 serotypes) 1. pneumonia 
2. meningitis 
3. sepsis 
4. otitis media (children) 
STREPTOCOCCUS PYROGENES 
(GROUP A) 
1. M-protein (adherence factor, 
antiphagocytic, antigenic) 
2. lipoteichoic acid (adherence 
factors) 
3. steptokinase 
4. hyaluronidase 
5. DNAase 
6. Anti-C5a peptidase 
1. Direct invasion/toxin 
     a. pharyngitis (purulent 
exudates on tonsils, fever, swollen 
lymph nodes) 
     b. sepsis 
     c.  skin infections 
     d. scarlet fever 
     e. toxic shock syndrome 
2. Antibody-mediated 
     a.  rheumatic fever (fever, 
myocarditis, arthritis, chorea, rash, 
subcutaneous nodules) 
     b. acute poststreptococcal 
glomerulonephritis 
Table 2. The various virulence factors coded for by two different strains of Streptococcus.  Also 
shown are the clinical manifestations of virulence factors.  
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Bacterial infections in respiratory diseases and medical 
implants 
 
Medical implants 
Thousands of patients worldwide undergo operations each year. With new technology, it is now 
common to get joint replacement surgeries and other kinds of medical implants. Such surgeries 
unfortunately still are not perfect, due to the high risk of getting prosthetic joint infections or 
other device-related infections, which leads to different complications, which may lead to 
prolonged rehabilitation and hospitalizations, removal of the prosthetic, loss of function and in 
some cases can lead to death [22]. Even though the mortality rate due to infections post-surgery 
is lower than ever, the amount of patients dying is not, which is due to the increasing amount 
of operations performed each year [23]. 
 
Pathogenesis 
Biofilm formation on a medical implant can have a crucial effect on the success of the operation 
and therefore the treatment. Due to the pathogen’s ability to increasingly become resistant to 
the antibiotics, the patients’ health becomes more and more compromised in time.  
 
 
 
Fig 2. The pathogenesis of device-associated 
infections centers on these three factors: 
Bacteria, host and device [25]. 
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There are three central factors when it comes to the devices, which all work together. Bacteria, 
host and device (figure 2). The presence of a device can, in itself, enhance bacterial virulence. 
Different kinds of bacteria use different adhesions to colonize medical devices. 
Analysis of a study of rats done by JL Yu et al, where the rats who had indwelling biliary implants 
had evidence of bacterial colonization and biofilm formation on the mucosal biliary surface, and 
the rats who did not have biliary implants did not, yields 5 major principles: (1) different 
bacteria may adhere differently to the same device material; (2) the same bacteria may adhere 
differently to different device materials; (3) the same bacteria may adhere differently to the 
same device material placed under different circumstances, including the medium in which the 
device is placed, if it is in a hydrophobic or hydrophilic medium, type of flow, if the flow is 
dynamic or stationary, and temperature; (4) in vitro inhibition of bacterial colonization of the 
device does not ensure anti-infective efficacy in vivo; and (5) the clinical benefit of a particular 
surface-modifying approach may vary from one application to another.  
Host factors can be divided into two groups: (1) host factors that can affect bacterial adherence 
of bacteria to the device, and (2) host factors that can either promote or inhibit the persistence 
of already adherent bacteria on the surface of the device [25]. 
When it comes to the device, there are more factors, like the source of the device material, the 
surface of the device, and the shape of the device, that has to be taken into account. In the table 
below (figure 3), it shows what kind of device material, source of device material, surface of 
device and shape of device favors bacterial adherence [25]. 
Device-associated infections can be introduced to the body in two ways: either at the time of 
implantation or through hematogenous seeding [24].  
Device related infections are classified into three categories; “early”, which occurs within the 
first three months after the implantation, “delayed” that occurs between three and twelve 
months after the implantation and “late” which occurs after twelve months [23]. The majority 
of arthroplasty infections occur in the 2 years following the prosthetic joint surgery [24].  
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‘Early and delayed’ is likely to occur due to pathogens introduced during the surgery, whereas 
‘late’ is likely to be hematogenously (taking place or spread via the blood stream) acquired. 
Early infections can be detected by noticing symptoms such as; the wound leaking or acute 
onset of fever, pain, swelling, effusion and erythema at the implant site. Untreated it can lead to 
chronic sinuses, late infection presents with worsening joint pain and in some cases an effusion 
and restriction of movement [23]. 
 
Risk factors 
The risk of getting device-related infections may be higher if the patient suffers from one or 
more of the following factors before the surgery is performed; previous joint arthroplasty and 
surgical site infection not involving the joint prosthesis, old age, diabetes mellitus, previous 
native joint infection, obesity, poor nutrition, skin disease and pre-existing joint disease.  
Those undergoing primary joint replacement can have a smaller risk of getting device-related 
infections than those who are undergoing revision of an existing medical implant [23]. 
   Fig 3. Types of device material, source of device material, surface of device 
and shape of device [25]. 
       Type of device material: 
- Polyvinyl chloride favors bacterial adherence more than does Teflon 
- Polyethylene favors bacteria adherence more than does polyurethane 
- Latex favors bacterial adherence more than does silicone 
- Silicone favors bacterial adherence more than does 
polytetrafluoroethylene 
- Stainless steel favors bacterial adherence more than does titanium  
Source of device material: synthetic favors bacterial adherence more than 
does biomaterial. 
Surface of device 
- Irregular favors bacterial adherence more than does regular 
- Textured favors bacterial adherence more than does smooth 
- Hydrophobic favors bacterial adherence more than does hydrophilic  
Shape of device: polymeric tubing favors bacterial adherence more than 
does wire mesh. 
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Occurrence in medical implants 
Table 3 shows the magnitude of the problem of device-associated infections. The problems 
differing between the different medical implants are both the infections rate and the mortality 
rate. If we, for example, look at bladder catheters, we see that the infection rate is relatively 
high at 10-30%, but the mortality rate is low, which means that under 5% of the actual infected 
patients die. Whereas if we look at the patients who get mechanical heart valves it is 1-3% that 
get infected, but here the risk of mortality is high at over 25%. Catheter infections are the most 
common device-related infections - this is due to the number of catheters inserted in patients 
every day. The mortality rate in other kinds of prosthetic implants, such as heart valves and 
heart assisting devices is much higher. Even though all medical implant related infections do 
not lead to death, the damages can be very severe, both physiological and psychological 
(especially in the penile and mammary implants). Furthermore, we need to consider the 
different risk factors as previously mentioned, hence, patients who are critically ill might not 
survive a bloodstream infection, whereas patients without previous medical problems may 
have it easier when it comes to survival. Fracture fixation devices are more commonly inserted, 
but are also more likely to become infected. This is due to the fact that open fractures lead to 
infection more than closed fractures do. Even though mortality is rare in some cases, e.g. in 
medical devices implanted in sexual organs, including mammary and penile, there is still a big 
risk of major disfigurement and serious psychological trauma. The true rates of device-
associated mortality may be even higher than the listed one. The chances of getting an infection 
with re-implanted devices exceeds that of first time by several-fold [25]. 
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Pseudomonas aeruginosa 
Pseudomonas aeruginosa is a species of Gram-negative, non-spore forming, motile bacteria that 
cause different human diseases; it is a persistent problem in cystic fibrosis (CF). CF is a life-
threatening disorder that causes severe damage to the lungs (figure 4). The condition affects 
the cells that produce mucus, sweat and digestive juices. The secreted fluids in people without 
CF is thin and slippery, but secretions in CF patients are thick and sticky, and can therefore plug 
up tubes, ducts and passageways, especially in the lungs and pancreas [28].  
Table 3. Magnitude of the problem of device-associated infections. [25] 
DEVICE ESTIMATED NO. 
INSERTED IN USA 
PER YEAR 
RATE OF 
INFECTION, % 
ATTRIBUTABLE 
MORTALITY 
BLADDER 
CATHETERS 
>30.000.000 10-30 Low 
CENTRAL VENOUS 
CATHETERS 
5.000.000 3-8 Moderate 
FRACTURE FIXATION 
DEVICES 
2.000.000 5-10 Low 
DENTAL IMPLANTS 1.000.000 5-10 Low 
JOINT PROSTHESES 600.000 1-3 Low 
VASCULAR GRAFTS 450.000 1-5 Moderate 
CARDIAC 
PACEMAKERS 
300.000 1-7 Moderate 
MAMMARY 
IMPLANTS, IN PAIRS 
130.000 1-2 Low 
MECHANICAL 
HEART VALVES 
85.000 1-3 High 
PENILE IMPLANTS 15.000 1-3 Low 
HEART ASSIST 
DEVICES 
700 25-50 High 
In this case the attributes for the mortality rate is low, <5%; moderate, 5%-25%; high, >25%. 
Numbers are estimated by analysis of market reports, review of the medical literature, 
personal communication with personnel form device manufacturing companies, and review 
of data provided by medical associations. 
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Despite the inflammatory response and intensive antibiotic therapy CF patients get, the 
infections caused by P. aeruginosa persist, and lead to respiratory failure, which requires lung 
transplantation or can lead to death of the patient. P. aeruginosa has adapted to the 
inflammatory defense mechanism of the respiratory and conductive zone of the lungs, and to 
antibiotic therapy. An important adaptive mechanism is biofilm formation [29]. 
P. Aeruginosa develops on solid surfaces exposed to a continuous flow of nutrients and form 
thick layers of differentiated mushroom- and pillar-like structures separated by water-filled 
spaces [27]. P. aeruginosa adapts to intense antibiotic therapy by forming mucoid biofilms 
(figure 5), and by conventional resistance mechanisms, which act synergistically to allow P. 
aeruginosa to survive for decades despite antibiotic therapy, while the lung tissue is gradually 
destroyed [29].  
Fig 4. Lungs of an autopsy of a patient who 
suffered of Cystic Fibrosis, and died due to a 
Pseudomonas aeruginosa infection [29] 
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P. aeruginosa is most likely exposed to aerobic as well as micro-aerophilic growth conditions 
due to the oxygen supplied by inhaled air and from the blood in the capillaries surrounding the 
alveoli, which furthermore provides polymorph nuclear leukocytes (PMNs) [30]. PMN are 
white blood cells characterized by an irregular shaped nucleus divided into lobes connected by 
strands of chromatin [31]. The mucus is introduced in the conductive zone (figure 6), by goblet 
cells and sub-mucosal glands, where it mixes with P. aeruginosa micro-colonies and the 
attracted PMNs. In the mucus, mutations in algT (algU) lead to motile non-mucoid P. aeruginosa 
that disperse form the microcolonies [30].  
 
Fig 5. The important properties of mucoid and non-mucoid phenotypes of 
Pseudomonas aeruginosa form the respiratory tract of cystic fibrosis patients. [29] 
PROPERTY MUCOID  NONMUCOID 
LOCATION IN THE LUNGS Respiratory zone 
Conductive zone in 
sputum 
Conductive zone in 
sputum 
BIOFILM FORMATION IN 
VITRO 
Yes Yes 
BIOFILM FORMATION IN 
CF LUNGS 
Yes No 
MOST IMPORTANT 
PHENOTYPE-RELEVANT 
GENETIC MUTATIONS 
mucA mucA + algT 
MOTILITY No Yes 
MULTIPLE ANTIBIOTIC 
RESISTANCE 
Seldom Frequent 
RESPONSIBLE FOR LUNG 
TISSUE DAMAGE 
Yes  No 
INDUCES PRONOUNCED 
ANTIBODY RESPONSE 
Yes No 
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Streptococcus pyogenes 
Streptococcus pyogenes is a Gram-positive pathogenic bacterium; it usually grows in chains or 
pairs. S. Pyogenes is commonly called the beta-hemolytic group A streptococcus (GAS), because 
it displays antigen A on its cell wall. GAS invades host cells and causes primary infections of the 
throat and skin but also causes scarlet fever and necrotizing fasciitis, commonly known as flesh-
eating bacteria syndrome [32][35]. Pathogenic GAS, like other Gram-positive bacteria are 
decorated with long protruding pilus-like structures. Pili, among many other bacterial factors, 
are believed to participate in the formation of biofilm. These pili are encoded by a variable 11 
Fig 6. The conductive and respiratory zones of the lungs [29] 
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kb pathogenicity island known as the fibronecting-binding, collagen-binding, T-antigen (FCT) 
region [33]. The pili of Gram-positive bacteria have been shown to promote biofilm formation. 
The FCT region also contains genes encoding several kinds of adhesions and transcriptional 
regulators [34]. The biofilm on the biotic surfaces develop in three steps: first - adhesion of 
planktonic bacteria, second - proliferation of the primary colonizers and the maturation of the 
biofilm, and third - previously sessile members of the mature biofilm detach and act as primary 
colonizers at different sites in the human body [35]. 
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Quorum Sensing - an overview 
All bacterial colonies have the ability to communicate through a system known as Quorum 
Sensing. QS has been observed in various species of bacteria as a system of relaying information 
and transducing responses when required. Bacteria have been observed to accumulate within 
a biofilm structure until cell density reaches an optimum level and QS signals induce any 
number of varied responses.  
Autoinduction is another name given to this system of bacterial communication due to the role 
autoinducing molecules play. Autoinducers are species-specific molecules secreted by bacteria, 
which can be recognized by other individual bacterial cells in the vicinity. It has been discovered 
that once a bacterial population reaches a specific cell density, and receptors in the cell 
walls/membrane of bacteria nearby pick up on the number of autoinduction molecules present 
in their vicinity, a cascade is set in motion through a transduction of these signals from the 
intercellular space to the intracellular space.  
It is also now evident that individual bacterial cells use this cell density dependant system of 
‘reading’ autoinduction molecules as a means of judging the number of bacteria of their own 
species in the colony and as markers of the presence of other bacterial species in the same 
colony. It is a language of molecules, which allows bacteria to differentiate and quantify 
themselves.  
Bacteria release autoinduction molecules as a regulation system that regulates gene expression. 
Proteins in their membranes bind with these autoinducing molecules and inform the bacteria 
that this is an autoinducer. Once autoinducing molecules bind with the receptor proteins at the 
correct frequency, indicating to the bacteria the ratio of the entire communities’ population, a 
transduction cascade is set in motion by these receptor proteins which may lead to induction 
of another receptor, gene expression, production of a protein or the production of genes that 
go on to synthesize proteins. The importance of timing this reaction to the number of bacteria 
present in this bacterial community is that one single bacterial cell cannot induce much of an 
effect, whereas a colony of bacterial cells working together to produce biofilm, virulence factors 
or bioluminescence is a more impactful endeavor.  
It is pertinent to mention that although bacteria share a universal system of signaling and 
communicating, the autoinduction molecules, receptors and systems, which are used to detect 
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them and the biochemical systems, used to transduce this information to gene expression in 
individuals, have a very high specificity according to species and function [36]. 
Bacteria also use QS signaling molecules as a kind of “voting” system. They exist in the same 
state of gene expression as they would in a planktonic state until proliferation may allow them 
to detect an optimal number of “votes” and therefore, optimal number of individual bacterial 
cells, they begin to express a new set of gene expression.  
The discovery of QS in bacteria can be traced to the study of the symbiotic relationship which 
exists between the Bobtail Squid and Vibrio Fischerii, a bacteria capable of producing 
bioluminescence that colonize two lobes on its underside. The squid uses the bacterial 
bioluminescent activity to create a stealth effect during its nocturnal feeding. The bacteria 
derive shelter, nutrition and proliferation as benefits of this symbiosis as the squid’s circadian 
cycle allow it to expel the culture of bacteria through specialized tubes during its day time sleep, 
whilst at this time the bacteria does not produce bioluminescence.  It has since been 
hypothesized that the bacteria produce bioluminescence as a result of autoinducing molecules 
[37]. In the case of Vibrio Fischerii, autoinduction leads to the production of the luciferase 
enzyme which creates bioluminescence by exciting a lulazine chromophore [38]. 
The QS observed in Vibrio Fischerii is harmless to human beings but it is evident that the basic 
system of transduction is similar to the ones in bacteria like Pseudomonas that create virulence 
factors and produce biofilm resulting in pathogenesis in human hosts, even though the system 
is based on the same principle, molecules produced by the two different bacteria show 
complete species specificity.  
 
A quorum sensing model in Gram-positive bacteria 
Gram-positive bacteria like Streptococcus can cause life threatening human infections once they 
adhere to human tissue in the form of biofilms as discussed in the previous chapter. Most Gram-
positive bacteria use a system of autoinducing molecules for QS, by producing oligopeptides 
(figure 7). They exhibit virulent behavior through the aforementioned cell-density dependent 
system [39]. Whereas they may produce biofilm through a similar system which can cause 
stubborn infections [46]. Quorum sensing is therefore responsible for two of the most 
important factors in species of Streptococci when it comes to its ability to cause infection in 
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human hosts and that is the development of biofilm and subsequent increase in virulence 
factors, for example a higher acidic pH tolerance [44]. 
 
 
 
The QS model widely accepted as depicting the QS system in most Gram-positive bacteria is one 
that involves a post-translationally modified protein transported outside the cell via an ATP-
binding cassette type transporter. This “shorter” peptide is now an autoinducer. Once optimum 
cell density and consequently optimum autoinduction ratio is achieved, a two component signal 
transduction system detects this autoinducer which leads to the transcription of target genes 
(figure 8). 
Fig 7. An oligopeptide which can be sensed extracellularly and intracellularly in 
Gram-positive bacteria.  
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At a point where cell density has reached optimum level, a protein is produced by the cell 
through the translation of a locus called a peptide signal precursor locus. This protein is then 
further modified by being cleaved and then transported outside the cell through an ATP-
binding cassette type transporter.  
ATP-binding cassette type transporters (ABC transporters) are transmembrane proteins which 
use the energy derived from the hydrolysis of ATP to ADP to transport these peptides outside 
the cell. The binding of ATP to the nucleotide binding domain of the ABC transporter changes 
the shape conformation of the transmembrane domain and the subsequent de-phosphorylation 
of ATP to ADP returns the shape conformation of the ABC transporter to its original form. The 
intracellular domain communicates between the transmembrane domain and the nucleotide 
binding domain (figure 9).  
 
 
Fig 8. The two component signal transduction QS model in Gram-positive bacteria [41]. Once a 
gene is translated into a protein, the protein is cleaved and transported outside the cell. At optimal cell 
density, a sensor kinase detects and transduces the ratio of autoinduction molecules in the surrounding 
environment to a response regulator sitting on a target gene which goes on to produce virulence factors 
- making this a two component signal transduction system.  
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The two component signal transduction system has a histidine kinase protein as one of its 
components in the cell membrane [41]. This kinase detects autoinduction peptides and once 
optimum concentration of autoinducers has been reached, histidine kinases can undergo auto-
phosphorylation which allows them to phosphorylate on a conserved histidine residue leading 
to the transfer of a phosphoryl   group to a cognate response regulator protein [40], part of the 
two component signal transduction system in Gram-positive bacteria. The transfer regulator 
protein is phosphorylated on a conserved aspartate residue. This allows the regulator to 
activate the transcription of target genes (figure 10) [41]. 
The cell density dependent phenotype is derived from the gene expression of the transcription 
that occurs after the two component signal transduction system detects the autoinducers [39]. 
Cell density dependent phenotypes can be virulence factors [43].  
 
Fig 9. Proposed mechanism of ABC transporter proteins [41]. TMD: transmembrane domain, ICD: 
intracellular domain, NBD: nucleotide binding domain. An altered oligopeptide is being actively 
transported outside the cell by an ABC transporter protein.  
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Competence stimulating peptides 
Competence stimulating peptides are 17-amino acid autoinducers. They play a central role in 
the two component transduction system of most Streptococci, they are the peptide molecule 
used in these systems to transduce gene expression of various two component signal 
transduction systems.  A competence stimulating peptide can induce a QS cascade that 
increases the ability of bacterial cells to take up extracellular DNA, as much as 10 - 600 fold [46] 
compared to bacterial cells of the same strain in a planktonic state. This allows for a higher rate 
of transformation in such cells, resulting in the production of virulence factors. A competence 
stimulating peptide may also play a role in activating the use of an autolysis pathway to provide 
 
Fig 10. The production of cell-density-dependent phenotype. A peptide-pheromone precursor is 
coded for by a specific gene, this precursor is then modified before it is actively transported out of the 
cell, once a specific cell density is reached due to the proliferation of other bacterial cells in the 
extracellular environment, a two component signal transduction system transduces this information 
which allows a response regulator to alter gene expression by producing a different phenotype. [39]. 
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nutrients and extracellular DNA for the formation of the biofilm matrix. Autolysis is carried out 
when nearby cells predate on such cells, releasing DNA and virulence factors [45].  
 
The ComDE, Com AB and competence stimulating peptide auto-regulatory circuit 
The ComCDE gene codes for the precursor to the competence stimulating peptide, the histidine 
kinase receptor for this peptide and the response regulator that activates the ComCDE and Com 
AB operons in Streptococci.  Whereas a second two component signal transduction system, the 
CiaH-CiaR (figure 11), negatively regulates the ComCDE gene expression.  
 
 
 
Figure 12 shows the pathway followed from production to transduction by a competence 
stimulating peptide [44]. Once the competence stimulating peptide starts a positive feedback 
cascade allowing for an accelerated expression of ComCDE and ComAB transcription. This in 
turn allows the bacteria to be ‘competent’ in taking up extracellular DNA resulting from gene 
 
Fig 11. The ComCDE, ComAB and ComX auto-regulatory QS circuit showing a negative feedback two 
component signal transduction system CiaH-CiaR [46].  
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expression of the ComX gene by an alternative sigma factor allowing for altered phenotype, for 
example the increased tolerance for varying pH when bacterial cell density is high [44]. 
 
 
 
Competence stimulating peptides can therefore be considered valid and important targets for 
the development of novel methods of antimicrobial treatment, since analogs of competence 
stimulating peptides have been observed to outcompete the bacteria’s own peptides and 
disrupt the QS cascade associated with it [47].  
Inactivation of some of the mentioned QS circuits in Streptococci have also shown the 
development of abnormal biofilms suggesting that the same circuitry also codes for biofilm 
architecture in colonies of Gram-positive bacteria (figure 13) [46], furthering the case for 
development of analogs of competence stimulating peptides as novel antimicrobial treatment. 
 
 
Fig 12. Auto-regulatory circuit in Streptococci [44]. The ComCDE, ComAB and ComX operons are 
regulated through a cell density, and therefore competence stimulating peptide density, based auto-
regulatory QS circuit.   
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Fig 13. a + d: Normal biofilm formed by a parent strain, NG8 Wild Type, b + e: Aberrant biofilm formed 
by a mutant strain that is defective in producing a competence stimulating peptide, c + f: Restoration 
of normal appearance when synthetic competence stimulating peptide is added to the mutant strain. 
Pictures in a, b and c: Scanning confocal laser microscope images top view, pictures in d, e and f: side 
view. 
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Quorum sensing in Gram-negative bacteria 
P. aeruginosa uses QS molecules in order to achieve pathogenesis by activating certain virulence 
factor genes. P. aeruginosa uses three known quorum sensing mechanisms [48], two of which 
correlate with each other as the major QS system and the other which is supposedly activated 
between them.  
The two systems which correlate as one are the Las and Rhl QS systems in which they form the 
LasI/R-RhlI/R QS system. The LasI protein produces a homoserine lactone (HSL) as its 
autoinducer which binds to LasR. The LasI autoinducer, however, also activates the 
transcription of RhlR causing the second QS system to be initiated. Then, the RhlI protein 
produces its own HSL autoinducer which binds to RhlR in order to activate the transcription of 
another set of virulence factor genes (Figure 14). Furthermore, the Pseudomonas quinolone 
signal (PQS), the third QS system described below, is another regulatory link between the Las 
and Rhl QS systems [49].  
 
 
 
 
Fig 14. The pathways in the P. aeruginosa LasI/R-RhlI/R QS system. HSL autoinducers produced by 
LasI and RhlI are shown as triangles and pentagons respectively.  The receptor proteins for each system 
are shown as circles with a piece cut out in the shape of the autoinducers specific to that receptor. 
Disruption of Quorum Sensing as a Viable Treatment for Biofilm 
 
33 
 
The LasI/R-RhlI/R virulence factor QS system in P. aeruginosa 
The Las and Rhl HSL system, the major QS system, uses N-(3-oxododecanoyl) homoserine 
lactone (C12) as its major QS inducing molecule (Figure 15a) [50] [51]. 
The C12 molecule is synthesized by bacteria in order to coordinate QS as C12 activates host cell 
responses [52]. 
The lactone ring is the common part of the structure of all HSLs used in Gram-negative bacteria, 
and the acyl side chain, as shown in Figure 15b, is specific to P. aeruginosa which indicates the 
precise species specificity which therefore allows each molecule to interact with their specific 
protein receptors and no other. Thus, allowing the HSL molecules to facilitate the formation of 
communities through QS. In Figure 15c, the Vibrio Fischerii (another Gram-negative bacterium) 
HSL molecule has been placed with the P. Aeruginosa HSL molecule in order to show the species 
specificity, as the LasI/R autoinduction gene products in P. aeruginosa are very similar to the 
LuxI/R autoinduction gene products in V. Fischerii. Due to these similarities both sets of 
autoinduction gene products seem to result in similar regulatory processes [53].  
As mentioned before, HSL are used as the induction molecules for QS in P. aeruginosa, and are 
produced from LuxI type enzymes known as LasI. The receptor proteins used by P. aeruginosa 
are the LasR and RhlR regulator molecules which are part of the LuxR transcriptional regulator 
family. LasI enzymes produce the N-3-oxododecanoyl-homoserine lactone (3OC12- HSL) 
autoinducer which binds to cytoplasmic LasR receptors which activates the transcription of 
many QS target genes including RhlR – bringing forth the second QS system [50]. RhlI enzymes 
produce the N-butyryl-homoserine lactone (C4-HSL) autoinducer which similarly binds to the 
RhlR receptor, then controlling the activity of target promoters [49]. Thus, it is clear that the 
LasI/R system controls the first wave of QS-controlled gene expression and RhlI/R controls the 
second wave [50] and so controlling the virulence factors in P. aeruginosa (Figure 16). 
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As LasR and the HSL autoinducer are in charge of gene expression which may account for 
expression of important virulence factors required for pathogenesis in P. aeruginosa, they need 
to constantly be prepared for high level expression of genes such as LasB (also known as 
elastase, important for the breakdown of proteins)[53] and pyocyanin [50] for example. Thus, 
expression of LasI needs to be coordinated in order to produce sufficient amounts of 
autoinducers necessary for when the expression of various virulence factors is required. It was 
shown, in some current studies, that the LasI expression was reduced by a P. aeruginosa mutant 
strain, namely, LasR2 mutant PAOR1. So it was tested whether LasR could increase LasI 
expression and was found that it did have an effect but a Pseudomonas autoinducer was also 
necessary to activate LasI expression by a regulatory loop (Figure 16).   
 
         
a. HSL molecule C12 
 
b. C12 
 
c. V. fischeri and P. aeruginosa HSL molecules 
Fig 15a, b, c. 
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The virulence factor genes in P. aeruginosa have their own individual operators with similar 
LasR and autoinducer regulating elements separate from the LasI operator. This indicates that 
the LasI, LasR and the virulence factor genes are all part of a larger regulon. Therefore, some 
form of hierarchy must be present in order to ensure that enough LasI is provided in order to 
fulfil the autoinducer requirements required for activation of virulence factor genes.  
Also, in a current scientific experiment, it was seen that LasI expression was at its peak by day 
4 and during the biofilm formation the expression of RhlI fluctuated, seemingly due to varying 
amounts of iron present at times [49]. 
In some P. aeruginosa studies, in order to control the LasI expression, exogenous autoinducers 
have been added and it was found that the expression of LasI related with the synthetic 
autoinducer added until a flooding concentration was reached [53].  
HSL based quorum sensing systems are known to be antibacterial agents which work as a sort 
of survival strategy for these systems as they can grow in continuous flowing systems, even in 
Cystic Fibrosis patients lungs and can therefore achieve pathogenesis [54].  
 
Pseudomonas quinolone signal (PQS) 
PQS works together with the Las and Rhl systems in QS, as the expression of PQS is dependent 
on LasR expression and PQS then induces RhlI transcription, showing a link between these 
separate QS circuits. So PQS seemingly only initiates the Rhl circuit once the LasI/R circuit has 
been established and so producing the RhlI-directed autoinducer, allowing for the rest of the 
Rhl system to commence [49]. 
 Fig 16. Lasl/R and Rhll/R HSL Quorum Sensing systems 
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The PQS QS system uses 2-alkyl-4-(1H)-quinolones (AQs) as signal molecules, however in P. 
aeruginosa, 2-heptyl-3-hydroxyl-4-quinolone, is the specific key molecule. PQS is a secondary 
metabolite that works as a QS molecule and its key molecule acts as a strong agonist of the pqsR 
transcriptional regulator, therefore driving the expression of various virulence factor genes as 
well as biofilm formation.  Supposedly, PQS functions in the release of extracellular DNA used 
in the extracellular matrix formed around biofilms [55]. 
PQS acts as a coinducer for the pqsR regulator (also called mvfR (multi virulence factor) 
regulator) which regulates virulence factor genes [56].  PQS is also known to be an iron chelator 
and the synthesis of both, PQS and the PqsR-PQS activity are involved in iron homeostasis 
therefore, PQS is not only important as an autoinducing signal [49].  
Furthermore, controlled levels of iron (Fe), specifically Fe3+, is needed for growth and 
functioning of key enzymes which are involved in various processes, for example, DNA 
synthesis, to name one. It has also been found that high levels of Fe are important for organism 
growth; however, higher levels than necessary are essential in the formation of biofilms [57]. 
P. aeruginosa uses pvdS as its responsive transcriptional Fe regulator which is controlled by the 
Fur (ferric uptake regulator) which basically has control over the QS signaling between the Fe 
cells in bacteria.  
 
Phosphate uptake in P. aeruginosa  
P. aeruginosa also requires certain levels of phosphate in order to attain ATP (adenosine 
triphosphate) and other cell components. When there is a limited amount of phosphate 
available, it has been seen that swarming motility is used to regulate this scarcity. It uses two 
phosphate uptake systems – “Pit, a low-affinity, constitutively operating channel, and Pst – a 
high-affinity ABC transporter”, the Pst system being used mostly.  This system is controlled by 
the pst operon which contain genes pstA, pstB, pstC, pstS and phoU. This system is regulated by 
PhoB/R genes which responds to and is activated by the depletion of phosphate. When 
phosphate levels get low, PhoR phosphorylates PhoB, which then acts as a transcription factor 
and activates the pst operon and other genes. The PhoB protein up-regulated the Rhl QS system 
in P. aeruginosa resulting in the secretion of rhamnolipids, which also induce swarming motility 
[48].   
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Possible targets for the disruption of QS 
Since PQS seemingly plays a relatively large role as a QS mechanism, it would be an ideal target 
to disrupt or completely prevent any form of infection such as P. aeruginosa from forming. 
Starving the bacteria from available Fe, together with host defenses concealing Fe as a potent 
mechanism to infections, has been found to significantly decrease the number of organisms in 
strains of P. aeruginosa so focusing on this is dire to the disruption of QS. However, some 
complications have shown in experiments of targeting this vulnerability as the majority of 
pathogens have redundant Fe uptake systems. P. aeruginosa specifically has more than 30 genes 
which encode Fe receptors [57]. Iron chelation therapy has also been used although not too 
successfully, causing secondary infections, as a few organisms use Fe too complicated for 
chelators. Targeting the Fe metabolism seems to be a good aim due to its vulnerability in 
organisms and the different levels of Fe that are required either for general growth or biofilm 
formation. 
 
 
 
 
 
 
Fig 17. QS initiating variabilities. “Small populations of clonal cells initiate QS upon confinement and do 
so with marked variability. A)–C) Three adjacent droplets, each containing a small population of cells at 
time zero, show variability in initiation of QS after 8 h. White arrows point to cells that did not initiate QS; 
green arrows point to cells that initiated QS.” [54] 
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Not all cells in P. aeruginosa have activated QS systems, regardless of the conditions grown in, 
which, is allegedly due to inherent variability. Some current studies have clarified this from 
results showing QS initiation of small groups of P. aeruginosa cells in even confined areas, 
regardless of the material used in confinement or whether they were covered by air only (figure 
17) [58].  
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A new generation of antibiotics 
In both Pseudomonas and Streptococcus, quorum sensing is vital in the process of forming a 
potent biofilm. In both strains, quorum sensing regulates cell-density dependent gene 
expressions and controls a variety of virulence factors, all a link in the chain that is forming a 
biofilm [59] [60]. 
 This naturally leads to the conclusion that for bacteria to form a potent biofilm, quorum sensing 
signaling molecules must be present, and that disruption or inhibition of this cell-to-cell 
communication will lead to production of a less potent biofilm or even degradation of an 
already formed biofilm. Alteration of the gene expression responsible for producing or 
receiving quorum sensing signaling molecules is also a possibility. Where traditional antibiotics 
are having a bactericidal focus, research on novel treatment is being led into a more 
bacteriostatic direction, meaning that altering bacteria gene expression and phenotypes or 
disrupting QS and its natural metabolic pathway is being focused. 
A last way to go could be exploiting the fact, that bacteria do have some natural “predators” 
called bacteriophages - organisms that like viruses, infest the host bacteria cell and kill it. 
 
Antibiotics targeting gene expression 
As mentioned earlier, a new generation of antibiotics is needed to combat the problem of 
biofilm formation, and whereas the current generation is focusing on killing the bacteria, the 
new generation will target things like the bacterial gene expression. 
The aminoglycoside called tobramycin seems to be very potent at this, but so far only in-vitro, 
in this case (Figure 18) on the environmental strain, P. aeruginosa PUPa3.  
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Tobramycin is a molecule produced by Streptomyces Tenebrarius, and it has been determined 
that this specific molecule is in fact inhibiting the RhlI/r QS system of P. aeruginosa PUPa3, by 
binding to the prokaryotic 30S ribosomal subunit, interfering with protein synthesis, leading to 
a reduction in the production the QS signal molecule C4-HSL [61]. 
As seen in figure 1, the inhibition of this certain molecule leads to inhibition of the swarming 
motility of this particular strain of P. aeruginosa, meaning that attacking the gene expression of 
the bacteria might be the right way to go for a new generation of antibiotics. This also shows us 
that if quorum sensing is disrupted, bacterial swarming will not occur, giving the new 
generation of antibiotics a clear direction. This leaves us with the problem of the 
exopolysaccharide component of the biofilm, where the answer seems to lie with the efflux 
pump of the bacteria.  
The problem with this sort of treatment could be the extracellular matrix of a biofilm, since it 
seems that the tobramycin treatment has none or very little effect on a biofilm formed in a 
catheter-like environment, meaning that the drug might be blocked by the exopolysaccharide 
produced by the bacteria, and therefore it won’t be able to reach the bacteria. Also, the 
multidrug resistance potential of bacteria encased in biofilm is a challenge for this sort of 
treatment [62]. 
Fig 18. Effect of tobramycin on swarming motility in P. aeruginosa: 
A) The bacteria swarms unhindered. B) Swarming is highly inhibited 
in the presence of tobramycin. C) Swarming is restored by adding 
synthetic C4-HSL 
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The efflux pump 
The efflux pump is, as earlier mentioned, an active transport protein, located in the cytoplasmic 
membrane of most cells. It is categorized in 5 different families, depending on protein structure, 
mechanism of action and source of energy [63].  
In P. aeruginosa, the efflux pump has also been recognized as a vital part of the biofilm 
formation sequence, since it seems that the efflux pump is part of the metabolic pathway, in a 
way that disruption of the pump leads to inhibited production of curli, long thin fibers attached 
to the bacteria’s exterior (figure 19), that play a large role in biofilm adhesion [64], as well as 
matrix formation in strains such as E. coli, Salmonella and P. aeruginosa [65]. 
 
 
 
The curli-production is a very complex and not fully understood pathway in the bacteria, and is 
unique for every different bacteria, but what seems to be common for every bacteria, is that the 
curli is produced by membrane proteins [66]. This could explain why inhibition of the efflux 
pump, a membrane protein, is also disrupting the regulation of curli in the bacteria. Since curli 
fibers have proven to be playing an important role in cell aggregation, adhesion to surfaces and 
biofilm formation, inhibition of the efflux pump leading to less curli fibers being produced could 
prove to be a viable treatment method, also because the treatment seems to work both in static 
and flowing assays, and on both new and mature biofilms, meaning that this could be a way of 
  
Fig 19. Here the curlifibres are seen next to the flagella (responsible for bacteria 
motility) and the Pili, or fimbrae which together with the curli, are responsible 
for adhesion and biofilm formation. Curli is also known as thin fimbrae fibers. 
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treating both respiratory diseases as well as infections on implants and catheters [65]. This 
treatment method has not made it to clinical trials yet, but so far the in-vitro experiments have 
produced promising results. 
Inhibition of the efflux pump can prove useful, because despite being seemingly effective in 
biofilm disruption, the inhibition of the efflux pump should be reducing the resistance of the 
bacteria, leaving it vulnerable to traditional antibiotics. Research has shown that a combination 
of efflux inhibitors and antimicrobial agents can result in reactivated activity of the certain 
compound, meaning that efflux inhibition would not only be effective by itself, but could also 
prove to increase the effectiveness of already discovered antibiotics [67]. 
 
Bacteriophage therapy 
Bacteriophages are very similar to the viruses infecting humans, except they only infect 
bacteria. The lifecycle of a lytic bacteriophage is illustrated and described in Figure 20. 
 
 
 
Fig 20. The lifecycle of a lytic phage: (1) The phage attaches itself to a specific host bacterium 
(2) The phage injects its DNA into the bacterium (3) The phage then kills the host bacterium (4) 
It then proceeds to take over and use the bacterium’s DNA and protein synthesis machinery to 
reproduce itself (5) It culminates in the assembly of new phages (6) It breaks down the bacteria 
cell wall, to release hundreds of new copies into the bacteria colony [67] 
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There are two main features of the phages, which in theory could make them useful in treatment 
of biofilm infections. The first feature is the “lock and key”, meaning that phages only attack 
very specific bacteria, where they can identify specific surface proteins.  
Secondly the bacteriophages will after a successful infection, reproduce exponentially on the 
site of infection, meaning that very little concentrations of phages are needed in order to kill a 
population of bacteria [68]. 
The bacteriophages excel at killing the bacteria but to do that, they need to infect the bacteria, 
which means the specific surface protein needs to be present. Since no major breakthrough has 
been made in the phage therapy area for decades, this could prove to be the biggest weakness 
of this treatment. Phages might prove to be too specific, meaning that if a mutation occurs in 
the bacteria leading to the lack of this specific surface protein, the phages will not be able to 
infest the bacteria, and therefore not be able to effective at all. 
Theoretically, phage therapy should be an ideal way to treat a biofilm infection, but because of 
the bacteriophages incredible specificity it hasn’t been able to rid us of the biofilm problem. The 
thing is that the bacteriophages are focusing on killing the bacteria, inducing “survival of the 
fittest” in the biofilm, meaning that if just a few bacteria manage to survive because of some 
mutation, they will multiply, causing the mutation to render the replicated bacteria immune to 
the phages as well, causing resistance throughout the biofilm. 
Even though bacteriophage therapy has proven to be ineffective through the last couple of 
decades, the area is still being researched for a potential breakthrough. To deal with the 
bacterial exopolysaccharides, phages have been engineered, so that their surface expresses 
enzymatic properties, meaning they will be able to gnaw their way through the matrix and get 
in contact with the bacteria [69]. For this to work, specific phages would still be needed, since 
different kinds of phages infect different kinds of bacteria. This method is not dealing with the 
potential resistance a biofilm could develop to phage therapy, but instead dealing with the 
challenge of the biofilm matrix. 
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Quorum quenching 
 
Quorum sensing interference also known as quorum quenching suggests a promising disease 
control strategy since quorum sensing mechanisms appear to play important roles in host-
pathogen interactions. In our report, we are mainly going to be focused on quorum quenching 
on the Pseudomonas aeruginosa (Gram-negative) and on Streptococcus (Gram-positive) 
bacterium. These two bacterial species are considered clinically significant given their ability 
as opportunistic pathogens to repeatedly mutate and resist traditional antibiotic treatment and 
their causal implication with morbidity and mortality. Their clinical significance has also given 
rise to a plethora of literature and research which we were able to review in the context of our 
paper [90]. 
 The interruption of quorum sensing can be done in many different ways, namely: 
 Suppression of synthase and receptor activities, stabilities or productions. 
 Inhibiting the production of QS signal molecules  
 Antagonizing signal binding to luxR-family receptor. 
 Trapping signals 
 Enzymatic degradation of QS signal molecules AHLs [70] 
 Unknown mechanism by macrolide antibiotics 
The mechanics of these methods will now be further articulated.  
 
Synthase suppression, receptor competition and interference 
It is understood that some quorum sensing bacteria have regulatory elements which obstruct 
the progress of their cell to cell communication. It is suspected that the reasons behind the 
physiological implications of these inherent modulations are tightly controlled repressions of 
QS genes under a threshold population, slowing of the fine-tuning of its activity at a specific 
level and delays in quorum sensing initiation [72]. Taking advantage of these implications by 
artificially manipulating their function at the cel1lular level will then allow use as a target for 
QS inhibition by controlling cell to cell communication. 
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In Pseudomonas aeruginosa, it is the anti-LuxR activators that have been reported to inhibit 
quorum sensing activation. These mutants confer constitutive AHL signal accumulation even in 
the absence of the quorum sensing initiator, octopine. They also confer hyper-plasmid 
conjugative transfer competence with extreme activation of the quorum sensing for example 
Qs1A which is an anti-LasR protein in P. aeruginosa. 
It doesn’t take a high level of quorum sensing for the null mutant strain qs1A to respond as 
compared to its parent mutant strain which means that there is higher QS activity – for example, 
higher elastase production and exoprotease. Virulence in a drosophila infected model (which is 
a developmental microcosm that has been used a lot as a model for early development and 
recently in wound repair) is suppressed by QscR which is an orphan LuxR-family protein in P. 
aeruginosa. It does so by inhibiting a number of LasR- Rh1R-activated genes by protein-protein 
interactions with LasR and RhlR [74] (figure 21). 
 
Quorum sensing signal molecule inhibition  
Interference of AHL synthesis is a sure way approach of attaining quorum quenching. Simply 
put, no cell communication occurs if no AHL is produced. As studies in AHL synthesis have 
shown, when a C8-HSL analogue binds to AHL synthase, enzymatic activity is inhibited. It can 
be done by using the Luxl inhibitor or by blocking the SAM (S-Adenosyl methionine) 
biosynthesis. (Figure 22) 
 
Fig 21. Anti-receptor. The process of 
LuxR suppression [71]. 
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LuxR family receptor antagonist  
In QS, the first step in the communication of the cells is to bind a specific AHL signal to a LuxR 
protein. Therefore anything that interferes with the receptor binding (AHL) is a potential QS 
inhibitor. In general analogues are antagonists of the native AHL signal. In P. aeruginosa, the 3-
oxo-C12-HSL was shown to inhibit the binding of native AHLs with particular focus on the length 
of the acyl side chains. The cognate receptors have the ability to bind some analogues at a higher 
attraction than native AHL ligands, in doing so the analogues become antagonists by 
inactivating gene expression. The AHL fits into the apo-LuxR to form the active form (holo-
LuxR) when the antagonist is put in, then it inactivates the holo-LuxR (figure 23). 
 
 
Fig 22. Signal synthesis inhibition 
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Trapping signals 
This method of QS attenuation came about after it was discovered that cell communication does 
not occur when the AHL concentration is maintained below a threshold level, hence, an AHL 
interceptor would act as a QS inhibitor if implemented. C4-HSL, a lactone from Pseudomonas 
aeruginosa, can be trapped and this results in the decrease in the production of the quorum 
sensing-induced red-pigment.  
Cyclodextrins, a group of structurally related natural products formed during bacterial 
digestion of cellulose, which form stable aqueous complexes with numerous organic 
compounds, have been used for this method [74]. Clathrate compounds are used in this process 
since they are chemical substances that consist of a molecule trapping lattice (figure 24). 
 However, it should be noted that at this time, use of cyclodextrins as QS inhibitors is still 
immature.     
 
Fig 23. Antagonist for receptor 
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Enzymatic degradation of AHLs 
Synthesizing and secreting the signal molecules into the extracellular medium allows 
interference with their accumulation either by inactivating them or completely degrading 
them. A target of such therapy can be the PQS in Pseudomonas. The two types of enzymes that 
are known to be able to degrade the AHL signal molecules are AHL-lactonases and AHL-
acylases. The first of the 2 mentioned is a catalytic enzyme that cleaves the homoserine 
lactone ring whilst the last catalyses the hydrolysis of an amide bond between the homoserine 
lactone moiety and a fatty-acyl group. The degraded AHL products are no longer active in QS, 
therefore, the phenomenon is often called “quorum quenching”. 
The AHL-lactonases hydrolyse the lactone ring in the homoserine moiety of AHL’s without 
affecting the structure of the signal molecule any further [73]. AiiA, which stands for Auto 
inducer inactivation, is an enzyme that inactivates the AHL QS signal and is produced by the 
Gram-positive Bacillus sp, when used in Pseudomonas aeruginosa strain PA01, we notice a 
decrease in virulence factors elastase, rhamnolipids, pyocyanin and cynide production levels. 
Despite this being a good source of QSI, it also has its disadvantage which is that the lactonolysis 
reaction is reversible at acidic pH (figure 25 a). 
 
 
Fig 24. Signal trapping 
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The second enzyme used, AHL-acylases also degrades the AHL signal molecules. What it does 
is it attenuates virulence in P. aeruginosa. The HacB enzyme produced by P. aeruginosa PA01 
hydrolyses the amide bond between the acyl chain and the homoserine lactone in the AHL 
molecule, consequently producing the corresponding free fatty acid and homoserine lactone 
(Figure 25 b) [76]. In an experiment conducted in 2003 by Lin et al, the AiiD acylase enzyme 
was expressed in P. aeruginosa PAO1 and it showed some insightful effects on the virulence of 
the pathogen. Its swarming ability was reduced in the presence of the AiiD HSL-acylase and it 
also saw a reduction in the production of virulence factors such as elastase and pyocyanin. It 
also demonstrated to us that AiiD might in the future, be used to as effective antimicrobial 
therapeutic agents since they can weaken the virulence of P. aeruginosa. 
 
Macrolide antibiotics 
Macrolides have been shown to possess QS inhibition properties for P. aeruginosa. The 
antibiotics have large sized molecules and are relatively hydrophobic. These two features have 
led scientists to believe that they would not have an effect on Gram-negative bacteria due to 
their exclusion from the bacterial cytoplasm and low permeability since they’re hydrophobic 
[77]. 
Clinical reports however show a different story, a rather surprising one at that. They show that 
long term treatment with macrolide antibiotics at sub minimum inhibitory concentrations (Sub 
 Fig 25. Modification of AHL signal 
Fig 25. Signal degradation 
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MIC) actually eases the chronic lung infection disease caused by P. aeruginosa in patience with 
CF and it also diffuses pan-bronchiolitis. 
A few proposals as to what the actual mechanism behind these macrolide antibiotics is have 
been made. One proposal is that the macrolide antibiotics repress QS in Pseudomonas 
aeruginosa. It specifically represses the quorum sensing by C4-HSL synthases and the 
expression of las and rhl- activated gene/protein such as elastase, rhamnolipid and pyocyanin 
[78]. 
 
Streptococcus quorum sensing inhibition 
Gram-positive bacteria typically use small peptides as QS effectors and each QS circuit generally 
requires the communication of a single signaling molecule with a single receptor protein as was 
mentioned. Quorum sensing in Gram-positive bacteria has been found to regulate a number of 
physiological activities including competence development, antibiotic biosynthesis and 
induction of virulence factors [79]. 
It has been shown that analogues of quorum-sensing peptides can inhibit the activity of the 
peptide-mediated phenotype. It is generally understood that peptide signal–sensing systems 
are very similar among Gram-positive bacteria, therefore, an analogous inhibitor may provide 
broad-spectrum coverage when used.  
 
QS Inhibitors 
An effective QSI should be one that is chemically stable and resistant to degradation by various 
host metabolic systems, one that is preferably longer than the native AHL, one that is a small 
molecule with the ability to effectively reduce of the QS regulated gene expression and lastly 
one that is highly specific for the given QS regulator with no antagonistic effect(s) on the 
bacteria or host [80]. Using one of those inhibitors with such characteristics would result in the 
bacteria being most likely treatable and not becoming resistant to the drugs which generally 
exert selection pressure during treatment of infections and most likely will not affect the “good” 
bacteria protecting the host. 
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Types of quorum sensing inhibitors 
Natural inhibitors: 
With natural inhibitors, the quorum quenching is done by inhibiting the QS system through an 
extensive range of compounds. Some of these bioactive compounds have been considered as 
responsible for the QSI properties. A few examples of these compounds are ajoene (4, 5, 9-
trithia-dodeca-1, 6, 11-triene 9-oxide) in garlic extract, eugenol in clove extract, iberin in 
horseradish extract and ellagic acid derivatives in terminalia chebula [81]. What these 
compounds do is that they reduce production of virulence determinants like rhamnolipid and 
pyocyanin of the P. aeruginosa in vitro.     
Plants including; tomato, pea seedlings, garlic, chili, water lily, soybean, carrots to name but a 
few, all produce QSIs. They are all examples of natural inhibitors. 
Artificial/synthetic inhibitors: 
There are major limitations in natural inhibitors and that is they are produced in such small 
concentrations and also their level of toxicity (in some cases) is not so high. By chemically 
synthesizing them, we are able to circumvent these limitations. In spite of an obvious 
commercial value of synthetic analogues of QS signals and their interaction with transcription 
regulators, there is a shortage of such antagonists [82].  
Examples of artificial inhibitors include synthetic furanones (which are analogues of 
homoserine lactones that appear to interfere with the development of typical biofilm structure 
leaving these organisms more liable to treatment with natural biocides) as used in an 
experiment on mice injected with lethal P. aeruginosa infections [87]. What they did was to 
reduce the lung pathology and assisted in the bacterial clearance [83]. Garlic extracts, as was 
explained in the natural QSIs have ajoene as their bioactive compound. Synthesizing this 
bioactive compound and using it on mice injected with the P. aeruginosa bacterium, saw it 
promote clearance of the bacterium’s pulmonary infection on the mice which shows it as a QS 
inhibitor. 
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Bacterial reporters 
Detection of the pathogenicity issues related to quorum sensing is one of the most fundamental 
steps in trying to find ways to make QS inhibition viable. There is a large variation in QS signals 
produced by various organisms, therefore, bio-sensors are of immense importance so they can 
help in distinguishing which mechanism would work for which kind of signaling [84]. 
In order to establish the link between cause and effect, bio-monitor strains like AHL (Acyl 
Homoserine Lactones) receptors can be developed over a period of time. These bio-monitor 
strains allow sensitive, quantitative and real-time detection of QS signals such as the AHLs. The 
reporter strains lux operon and lacZ (which have a functional regulator protein but lack AHL 
synthase enzyme) are fused to the QS regulated promoter. Since the reporter strains lack AHL 
synthase enzymes, the promoter activity now gets prompted by exogenous QS signals. The 
receptor then gets triggered by the presence of AHLs which binds to its cognate promoter and 
initiates the expression of certain genes. The expression of the relevant genes is proportional 
to the concentration of the signal molecule [85]. In short, it mimics the natural QS system with 
certain easily recognizable phenotypes (table 4). 
 
 
 
Table 4. [86] 
ORGANISM QUORUM SENSING 
SIGNAL DETECTED 
PHENOTYPE REFERENCE 
PSEUDOMONAS 
AUROFACIENS STRAIN 30-84I 
C6HSL Phenazine 
antibiotic 
production 
Wood et 
al., 1997 
PSEUDOMONAS PUTIDA 
117(PAS-C8)-CEPR RECEPTOR 
C8HSL Green 
Fluorescent 
Protein 
Steidle et 
al., 2001 
P. PUTIDA ISOF⁄GFP 3OC12HSL Fluorescence Venturi, 
2006 
VIBRIO HARVEYI BB170 — 
LUXP RECEPTOR 
AI-2 Bioluminescent Bassler et 
al., 1993 
V. HARVEYI BB886 — LUXP 
RECEPTOR 
AI-1 Bioluminescent Bassler et 
al., 1993 
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Experiment   
 
Aim 
The aim of the experiment was to observe the behavior of biofilm growth over time and the 
degradation of biofilm with traditional antibiotics. The experiment was developed in such that 
we could observe the effects of treating planktonic bacteria before biofilm was formed, as well 
as those of treating established, mature biofilm. Another purpose of this experiment was to 
observe Pseudomonas solution cultures and to infer original bacteria density quantities and 
compare with empirically derived expectations for said strain growth-rates. We hoped to 
correlate our observed data with already existing understanding regarding development and 
behavior of biofilm, and treatment and growth-rates for planktonic bacteria. Although we had 
limited lab experience, we hoped to produce data in accord with the aforementioned behavior 
of biofilm and treatment efficacy as well as minimal inhibitory drug treatment concentrations.  
Two experiments were conducted in this endeavor, each spanning a total of three days, namely, 
Experiment 1 and Experiment 2. Experiment 1 was performed in order to observe the behavior 
of biofilm growth over time and to determine treatment efficacy of the traditional antibiotic 
Tobramycin on mature biofilm formed through overnight culture.  Cultures were diluted and 
plated in order to observe growth rates. For various reasons however, including human error 
due to limited laboratory experience, the data results from Experiment 1 were extremely 
sporadic and did not lend themselves to a conclusive analysis. These results included in the 
Appendix. Experiment 2 was performed through a slightly different method, with the 
expectation of improved results and a better understand of laboratory procedure. The material, 
method and conclusion of Experiment 2 are as follows:  
Material 
- LB media overnight tubes (5ml/ tubes) 
- LB plates 
- H2O autoclaved 
- 70% ethanol  
- 10mM Magnesium sulphate, pH 7 
- 0.1% crystal violet in water 
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- PBS 
- Biofilm assay plate 
- Eppendorph tubes 
- Pipette and tips 
- Centrifuge 
- Vortex 
- Bunsen burner 
- Test tubes 
 
Method 
An overnight culture of Pseudomonas was established with an unknown bacterial cell-density. 
From this overnight culture, 7 diluted solutions were created – each subsequent solution being 
a further-diluted solution by a factor of 10. Ranging from 1:10 – 1:1xe7, relative to the original 
overnight culture. Each of these solutions were then plated and incubated overnight for 
observation of growth rate and to infer accuracy of both the dilution and plating method.  The 
two highest dilutions (1xe6 & 1xe7) were plated 3 times by separate individuals in order to 
observe differing accuracies and obtain multiple data to infer original bacterial cell density.  The 
optical density of each dilution was recorded with the optical density reader after they were 
stained, spun and washed.  
The 1:10 dilution was used as the bacterial culture for the biofilm assay. 2.5 mL of 1:10 dilution 
of bacteria was diluted with 22.5mL of MgS04. First, a well with only MgS04 was set up as a 
negative control. Three wells were then set up as positive controls, with 900µl of untreated 
bacteria (1:10 diluted with MgS04). The remaining wells had 900µl of diluted solution added to 
them with 4 different concentrations of Tobramycin being added at: 0 hours (37min) and 4 
hours. The ‘4 hour’ time point had 3 wells for each concentration administered. The 
concentrations of Tobramycin used for treating the biofilm assay were 100mg/µl, 50mg/µl, 25 
mg/µl, 12mg/µl and 6mg/µl. The biofilms from wells with both time points and concentration 
levels were stained, rinsed and measured in order to quantify biofilm formation for each time 
point and treatment protocol. The ‘4-hour’/treated at 100mg/µl biofilm concentration wells 
should serve as data for comparing with minimal inhibitory concentration (MIC) treatment of 
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P. aeruginosa from standards provided by organizations like the Clinical and Laboratory 
Standards Institute. The lower concentrations at this same time point should validate that 
lower concentrations are ineffective. The positive control wells should serve as references for 
completely untreated mature biofilm values, while the negative control well should serve as a 
reference value for zero amount of biofilm formation (only PBS and no bacteria added).  
 
Results 
Optical density readings indicate a general trend for biofilm formation quantity being inversely 
proportional to concentration of Tobramycin treatment for both planktonic (time at 37 
minutes) and mature biofilm (4 hours) (Table 5, Diagram 1). Readings show that treatment of 
planktonic bacteria at all concentration levels at time 0 (37mins) results in lower cell density 
than treatment at all concentration levels on mature biofilm (4 hours, Table 5). The mean 
average of the positive control wells was 0.125 (Table 5). Minimum inhibitory concentration 
for treatment on mature biofilm resulted in an average of 0.077 cell density reading. There is a 
difference of 0.048 between the averages of minimum inhibitory concentration for treatment 
on mature biofilm and the positive control wells. This minimum concentration treatment on 
mature biofilm reading was 61.6% of the positive control untreated well reading. Minimum 
inhibitory treatment concentration at time 0 resulted in a 0.063 cell-density reading (Table 5). 
Treatment of 6mg/µl on planktonic bacteria at time 0 resulted in a reading of 0.083 and the 
average reading for treatment on mature biofilm with 6mg/ µl was 0.091 (Table 5). Bacterial 
solution dilution cell-density readings and visibly recorded colony values for the 1:e6 and 1:e7 
dilutions are as listed in table Y. R2 correlation value for data in table Y for the f(x)=a.xb model 
was 0.92. The paired values for the plated e^6 and e^7 dilutions are: 37/3, 7/2 and 48/6 (Table 
6).   
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CONCENTRATION 
OF TOBRAMYCIN 
(MG/UL) 
100 50 25 12 6 
ANTIBIOTICS AT 37 
MINUTES (TIME 0) 
0.063 0.042 0.048 0.043 0.083 
ANTIBIOTICS AT 4 
HOURS 
0.093 0.060 0.069 0.075 0.084 
0.068 0.062 0.068 0.077 0.090 
0.070 0.075 0.078 0.086 0.101 
NEGATIVE 
CONTROL 
0.051     
POSITIVE CONTROL 0.128 0.117 0.131   
 
Table 5. Optical density readings for biofilm assay.  Treatment with Tobramycin at time = 37 minutes 
and 4 hours at concentrations; 100, 50, 25, 12 and 6mg/ µl. Negative and three positive control wells 
containing no bacteria culture and untreated bacteria culture respectively.   
 
 
Diagram 1. Plotted data of optical density readings at specific tobramycin concentration    
levels on planktonic bacteria and mature biofilm formation at 4 hours. 
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DILUTION OPTICAL DENSITY 
READING  
CULTURE COLONIES  
1:10 0.119 Carpeted 
1:100 0.101 Carpeted 
1:1000 0.03 Carpeted 
1:E4 0.024 Carpeted 
1:E5 0.025 Carpeted 
1:E6 0.01 37 
1:E6 (I) Not recorded 7 
1:E6 (II) Not recorded 48 
1:E7  0.009 3 
1:E7 (I) Not recorded 2 
1:E7 (II) Not recorded 6 
 
Table 6. Bacterial solution dilution optical density readings. 1: e6 and 1: e7 plated 3 times each 
and colony cultures visibly quantified.  
 
 
Diagram 2. Optical density for 7 multiple dilutions of overnight Pseudomonas culture ascending 
dilutions by a factor of 10. 
 
R² = 0,9211
0
0,02
0,04
0,06
0,08
0,1
0,12
0,14
1 10 100 1000 10000 100000 1000000 10000000
O
p
ti
ca
l c
el
l d
en
si
ty
Dilution concentration
Optical density reading
Optical density reading Power function trendline
This R² value
proves that our 
data is in a 
approxemate 
declining 
correlation with a 
power function 
trendline
Disruption of Quorum Sensing as a Viable Treatment for Biofilm 
 
58 
 
Experiment conclusion 
The plotted and tabulated optical density reading data indicates that the traditional antibiotic 
Tobramycin does in fact effect planktonic bacteria as well as degrade biofilm. However the 
efficacy of the treatment on the degradation of biofilm is shown to be ineffective with a resulting 
optical density average (over the 3 readings) reading still standing at 0.077. We feel that the 
negative control well reading may have been the result of human error, due to the fact that 
there are multiple optical density readings that contain bacteria which actually have lower 
optical density readings than the negative control well which contained no bacteria. Therefore, 
we conclude that the negative control reading may have been much higher than it should have 
been. This would also imply that the disparity between the reading for the MIC treatment on 
mature biofilm and the negative control reading could be even greater.  This would further 
validate the statement that mature biofilm is intrinsically difficult to treat with the traditional 
antibiotic Tobramycin given the relatively high reading of 0.077, compared to the negative 
control well which possibly could have been much lower than the observed 0.051. We further 
posit that this supposition can be applied to many traditional antibiotics given the inhibitory 
mechanism utilized by Tobramycin, which is inhibition of ribosomal translocation at the 
ribosomal A-site, which affects the processing of polypeptides. This further implicates 
production of proteins and by extension - gene expression. Hence, Tobramycin is known as an 
aminoglycoside.  
According to our observed data the MIC on planktonic bacteria is shown to be significantly more 
effective than on mature biofilm formation. The data also shows that concentrations below the 
minimum inhibition level are increasingly ineffective as they are reduced. These observed data 
are consistent with empirically derived data.  
The bacterial solution dilution cell density readings correlate with the solution dilution values 
(r2 value of 0.92), and observed growth behavior was as expected. The two highest dilution 
platings were used to attempt inference of the original culture bacteria quantity. It would be 
expected that the quantity of colonies on these two higher dilutions would be related to each 
other by a multiple of ten, given that that was the dilution factor. However, the platings are not 
all close to being multiples of 10 of each other. This could be one of a few factors associated 
with laboratory technique, skill set and experience. If the dilutions were plated incorrectly then 
this would affect the colony numbers. Error could be accounted for in a number of ways 
Disruption of Quorum Sensing as a Viable Treatment for Biofilm 
 
59 
 
including use of contaminated pippete tips, using glass spreaders that were too hot, or still had 
traces of ethanol on them, failing to vortex the dilutions before taking a sample with the pipette 
– which could result in taking either a higher or lower bacterial concentration compared the 
overall concentration in the test tube. Contaminated tips could also result in higher plated 
colonies if they were contaminated with a higher diluted bacterial solution.  
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Discussion 
 
The literature reviewed for this report has highlighted the fact that traditional antibiotic 
treatment is not a viable way to continue treating bacterial infections, especially due to the 
increased resistance bacteria are capable of exhibiting against traditional antibiotics. Another 
reason why traditional antibiotics may eventually fail to suffice, is that they are much less 
successful at treating stubborn biofilm infections since bacteria aggregated in a polysaccharide 
matrix are capable of escaping host immune defenses and also pose a barrier, one that shelters 
them from traditional drugs capable of antibacterial activity.  
From the results of Experiment 2, it is evident that planktonic cultures treated with a traditional 
antibiotic like Tobramycin show the efficacy of this antibiotic as a successful drug for the 
treatment of planktonic bacteria. For example, the OD readings obtained after treating a 
planktonic overnight culture show a decrease in bacterial cell density as the concentration of 
Tobramycin increases. In contrast, OD readings of bacterial biofilm treated with Tobramycin 
indicate that its efficacy is reduced, with OD reading values of bacterial cell density ranging 
higher than those of planktonic culture treated with tobramycin of the same concentration, 
(Table 5, Diagram 1).  
We postulate that biofilm development through quorum sensing is responsible for the reduced 
efficacy of Tobramycin on biofilm bacterial culture as observed through our experiment. This 
would also be consistent with findings from reviewed literature and experimentation [46]. 
Once the Pseudomonas culture is plated, auto-inducing molecules relate bacterial cell density 
to individual cells, setting off the quorum sensing cascades induced in Pseudomonas, as 
discussed earlier. According to our own research on active mechanisms involved and the 
research and experimentation of authors cited in this paper, the consequential formation of a 
biofilm is probably the primary reason why the drug administered failed to produce as 
impactful an antibacterial effect. The biofilm encased bacteria were now surrounded by a 
barrier between cell and drug, attenuating the treatment efficacy of Tobramycin.  
Furthermore, bacteria encased in a biofilm matrix are capable of undergoing horizontal gene 
transfer, especially after point mutations, which increases potential for antibiotic resistance. 
Prevalence of resistance to Tobramycin and other aminoglycoside treatment is current and 
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ubiquitous [90]. The data we obtained from Experiment 2 clearly elucidates the crucial part 
bacterial aggregation plays in the efficacy of drugs that can be used to treat infection. Since it 
has also been documented that the most stubborn bacterial infections that cause sepsis in 
patients are those in which bacteria attain adhesion to human tissue or abiotic medical 
implants, more effective antibacterial treatment that address said issues viably are needed .  
Biofilm formation has been proven to have a definite link with quorum sensing [46], therefore 
QS disruption has potential in the degradation of biofilm. In streptococci, since a competence 
stimulating peptide (CSP) is responsible for various virulent competencies within a bacterial 
cell, conferred through a QS cascade set in motion by a competence stimulating peptide, the 
inhibition of CSP receptor sites like those present in the ComD has proven to be an excellent 
target for reducing virulence factors [91]. For example one in vivo study showed that modified 
CSPs successfully outcompeted Streptococcal CSP and prevented the transduction of the QS 
cascade responsible for allowing the cell to develop competence in DNA transformation and  
hence capable of producing virulence factors. The result was a reduced mortality rate for mice 
infected with Streptococcus pneumoniae which were treated with a modified CSP analog [91]. 
Similarly, another study has shown how analogs of CSPs have also shown potential in the 
retardation of biofilm growth in several strains of Streptococci [92]. Biofilm formation can also 
be retarded in Streptococci through the inactivation of certain QS systems.  
Biofilm growth in Pseudomonas on the other hand may be effected by the disruption of quorum 
sensing dependent gene expression that effects the activity of efflux pumps. Since the exudates 
that make up biofilm are transported out of the cell via transporters that are capable of doing 
so through appropriate gene expression related activity, antimicrobials which target them may 
have the potential of developing into viable treatments of biofilm related infection. The 
inactivation of some efflux pumps has also shown the improved ability of various classes of 
antibiotics in effecting bacterial biofilms [93].  
Furthermore, peptidomemetic compounds like phenylalanine arginyl β-naphthylamide have 
shown great potential in efflux pump inhibition. They work by outcompeting antibiotics and 
binding to efflux pump receptor sites, allowing the concentration of antibiotics to increase 
within the cell instead of being expelled and carry out antimicrobial activity [94]. One of the 
biggest hurdles for the clinical application of peptidomimetics is their toxicity [95].  
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It is evident that QS disruption has potential to become a viable treatment. In-vivo testing and 
has shown how QS in Pseudomonas can be disrupted in patients using quorum sensing 
inhibitory drugs like Azithromycin [78]. Studies have also shown that novel methods of 
treatment exploring the disruption of various parts of QS circuits, from auto-inducing signal to 
protein synthesis,  have potential for future use in patients suffering from bacterial infections.  
There are synthetic and natural sources for molecules that mimic QS signaling molecules used 
by bacteria. Mimicking molecules or analogs compete with the bacteria’s own QS molecules for 
QS signal receptor binding sites. Synthetic QS inhibitors have a good potential for drug 
synthesis as their production can be highly controlled and exploited industrially.  
We have evaluated that the future of antibacterial treatment may lie in bacteriostatic treatment 
rather than bactericidal. The nature of traditional antibiotic treatments like tobramycin poses 
an inherent selection pressure on rapidly reproducing bacterial populations, culminating in 
bacterial resistance. On the other hand, QS disruption targets the products of bacterial growth 
by retarding or shutting down communication, and this may not potentiate selection-pressure. 
Another way of treating infections, especially those which involve biofilm formation, can be the 
combination of both novel and traditional drugs, where a novel drug is employed to degrade 
biofilm and a traditional drug is used as an antimicrobial once biofilm formation has been 
attenuated to pose a bactericidal effect. Similarly, a traditional drug may be used in combination 
with a drug that inhibits efflux mechanisms in bacteria so that a bactericidal effect may be 
attained, especially in drug resistant strains.  
 
Conclusion 
 
It has been demonstrated that Disruption of Quorum Sensing is a viable and workable solution 
fundamental to controlling the inter-bacterial spread of virulence factors and fundamental 
gene-expression, with particular efficacy in biofilm implications. This is important treatment 
advancement that will lead to reduced infection levels in host-infection and post-surgical 
implant patients and alleviate the mounting dilemma of antibiotic resistant strains of bacteria, 
potentially synergistically, when utilized in conjunction with more conventional antimicrobial 
treatments. For the majority of Biofilm formations, neutralizing their virulent factors through 
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disruption of the Quorum Sensing cascade will inhibit the pathogen’s ability to successfully 
coordinate pathogenesis and aggregate in a poly-substrate matrix of biofilm which has also 
been demonstrated in our experiment to increase pathogen’s susceptability to treatment with 
antimicrobials such as Tobramycin.  
With the advantages of a comprehensive treatment protocol for the prevention of biofilm 
formation  to include Quorum Sensing Disruption becoming increasingly evident through 
research, what does the future hold? More experimentation and research will underscore the 
possibly vital role of quorum sensing in stemming the tide of the rampant rise of infection rates 
and subsequent resistent strains, and allow further projection of current demonstrative 
efficacy of quorum sensing disruption onto a broader spectrum of bacterial species which will  
have profound implications in terms of combatence of infectious pathogens with clinical 
significance.   
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Appendix 
 
First Experiment 
Aim 
The purpose of this experiment was to observe Pseudomonas cutures, and to infer original 
bacteria density quatities and compare with empirically derived expectations for said strain 
growth-rates. In addition, to observe the degradation of Pseudomonas-formed biofilm once 
mature biofim were treated with the antimicrobial drug Tobramycin.  
 
Material 
- LB media overnight tubes (5ml/ tubes) 
- LB plates 
- H2O autoclaved 
- 70% ethanol  
- 10mM Magnesium sulphate, pH 7 
- 0.1% crystal violet in water 
- The experiment was conducted over a 3 day period. 
 
Methods 
On day 1 we grew the bacteria colony and left it to grow in an incubator overnight. We did this 
following this method:  
 We took a test tube with some LB and made sure the lid was always turned upside 
down or placed on a sterile surface turned downwards so that no contamination falls 
into it. 
 We then went on to use a pipette tip to scrape off 2-3 mm of the colony  
 We then went on to sterilize the neck of the test tube by burning it for a few seconds 
with a Bunsen burner flame. 
 Then we wiped the extracted colony inside the neck of the test tube 
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 Then we slowly tipped the medium towards the colony and let it mix. We then closed 
the test tube cap again.  
  To thoroughly mix them together, we placed the test tube on a vortex mixer and 
labelled it. 
 We then stacked the test tube in a water bath rack at 37° (at 190 rounds per minute) 
 We made sure that the water level in the rack was on level with the test tube so the LB 
was completely covered 
For growing colony on agar plate in incubator from frozen strain: 
 We got LB plates from a cooled basement 
 Log strain in blue folder 
 For our incubation we chose: HJ001 wild type Pseudomonas aeruginosa 
 We then took a pipette box, ethanol and waste net to the basement (of building 15). 
We use a pipette 
to remove a smidge of logged bacterial strain from container - carefully since it was 
80°C. 
 We then smeared bacterial strain on LB plate 
 We then disinfected our hands with ethanol and discarded the pipettes carefully in the 
waste net. 
 We then used a stirring rod dipped in ethanol after burning off the ethanol on a burner 
to swipe a zig zag pattern on the LB plate so that the bacteria would grow easily in that 
area. 
 Put the LB plate in a plastic bag - and incubate at 37°C.  
 
Day 2: 
 Overnight solutions were removed from the incubator solutions diluted by 10 fold 
dilution from the undiluted solution down to 10e9. 
 Agar plates were plated with 50 ul from each of the dilutions and incubated overnight.  
 1 ml was taken from each of the dilutions and the bacteria was spun out at 13000 rpm 
for 2 minutes in the eppendorph centrifuge. 
 The supernatant was removed and 50 ul of crystal violet was added. 
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 We vortexed the pellet and the bacteria was spun out again as done above in the 
eppendorph centrifuge for 2 minutes at 13000 rpm. 
 The crystal violet was removed with a pipet and the pellet was washed with distilled 
water. The bacteria was vortexed and spun out again and repeated with fresh water 3 
times for 2 minutes at 13000 rpm. 
 The pellet was re-suspended in 1 ml 70% ethanol. The cells were spun down and the 
supernatant was transferred to cuvets and the optical density (OD) was read at 595nm. 
 The OD readings were compared with the bacterial counts (colony forming units) from 
the agar plates.  
 The P. aeruginosa biofilm formation was analysed in an abiotic static surface assay in 
polystyrene 24-well microtiter plates 
 A single colony from the agar plate was inoculated in 5ml LB overnight at 37 C in a 
shaking water bath. 
 The overnight culture was diluted 100 times and 800 ul of the suspension was added 
into the 24 well plates. 
o 2 wells were left as negative controls using fresh LB media. 
o After 30 min, 1h, 2h, 3h, 4h, 5h and 6h intervals the following procedures were 
done on both the control wells: 
o The bacterial suspension was removed carefully with a pipet and incubated 
further. 
o After the 6hrs, 1ml crystal violet was added and left for 5 mins. 
o The crystal violet was carefully removed and the well was rinsed with 1ml of 
distilled water 3 times. 
o 1ml 70% ethanol was added and left for 5 mins, then the ethanol was 
transferred to a cuvet and the OD was read at 595nm. 
 
 After one time point was completed this cycle was repeated on the following time point 
and so on. 
 100ul of Tobramycin was added to 3 wells and 100ul of Tetracyclin was added to 3 
wells and the last 2 wells were left as positive controls.  
 The plates were incubated overnight at 37 C without shaking in the incubator. 
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Day 3 
After incubation we removed the supernatant carefully with a pipette from all 10 wells. 
Thereafter, we added 1ml crystal violet to each well and left them for 5 minutes.  
After that we then removed the crystal violet carefully and rinsed each well with distilled water 
3 times (1ml each). We then added 1ml of 70% ethanol to each well and left it for 5 minutes. 
The last thing we did was to transfer the ethanol to cuvettes and read the OD at 595nm. We 
then tabulated our data. 
 
 
Results 
  GROUP 1          
DILUTION 1:10 1:100 1:1000 1:10000 1:100000 
OD OF SOLUTION ASSAY 0.107 0.021 0.003 0.001 0.001 
OD OF SOLUTION ASSAY AFTER BEING 
STAINED AND SPUN  
0.300 0.124 0.043 0.001 0.079 
CULTURE COLONIES Entirely 
carpeted 
Mostly 
carpeted 
Mostly 
carpeted 
About 700 About 400 
            
  Group 2         
DILUTION 1:10 1:100 1:1000 1:10000 1:100000 
OD OF SOLUTION ASSAY 0.321 0.060 0.007 0.000 0.000 
OD OF SOLUTION ASSAY AFTER BEING 
STAINED AND SPUN  
0.242 0.134 -0.025 -0.016 0.162 
CULTURE COLONIES Entirely 
carpeted 
Mostly 
carpeted 
About 
4200 
About 2400 About 1300 
 
